HomeNewsBusinessPrestige group's FY21 sales bookings at record Rs 5,461crore despite COVID blues

Prestige group's FY21 sales bookings at record Rs 5,461crore despite COVID blues

Prestige group collected record Rs 5,075.2 crore from customers against sales bookings, up 9 percent from 2019-20 financial year.

June 09, 2021 / 21:14 IST
Story continues below Advertisement

Realty firm Prestige Estates Projects Ltd's sales bookings rose by 20 percent year-on-year to a record of Rs 5,460.8 crore in the last fiscal year on better demand for its properties despite the COVID pandemic.

According to an investors presentation, the Bengaluru-based firm has achieved a record sales of Rs 5,460.8 crore during 2020-21 financial year. In volume terms, sales bookings increased by 25 percent to 8.16 million sq ft. The average sales realisation was at Rs 6,689 per sq ft in FY21.

Story continues below Advertisement

Prestige group collected record Rs 5,075.2 crore from customers against sales bookings, up 9 percent from 2019-20 financial year.

During the last fiscal, Prestige group had launched 11.85 million sq ft in FY21.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show